spacer
home > ict > winter 2017 > reality check
PUBLICATIONS
International Clinical Trials

Reality Check

Randomised controlled trials (RCTs) are the gold standard for drug approval to establish the efficacy of interventions, and pragmatic RCTs measure their effectiveness. Real world studies are referring to pragmatic RCTs for the purpose of this article.

In recent years, the UK has seen a shift in the NHS treatment of patients with ongoing chronic medical conditions from secondary to primary care. The NHS Constitution has promised that all eligible prospective participants are offered the choice and opportunity to take part in relevant studies (1). Therefore, in order to cultivate these developments and truly represent the study population, there needs to be a move away from traditional research studies that extrapolate results in other settings, to real world evidence obtained from patients in both secondary and primary care. This is because it could be argued that patients who attend research facilities are in an ‘artificial’ controlled environment, rather than reflecting real life clinical practice. Often, with traditional RCTs, many subjects have a single disorder under examination – meaning those with several co-morbidities are excluded and results can only be true in those with solitary disease profiles.

Real World Studies

This is where real world studies can prove invaluable. They are able to combat the above issues, plus complement the established phases of trial methodology by widening the inclusion criteria to include subjects with several comorbidities – thus allowing closer examination of real life subjects as opposed to generalisation of a population. Conversely, the data available in primary care are comprehensive, and strict selection of data values is necessary to avoid any unethical collection of data that would be discounted at the analysis stage.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Julie Millar is CK Aspire’s Community Research Nurse Team Lead. Prior to this role, she worked in the NHS in Renal Medicine and as a Community Practice Nurse specialising in respiratory. Julie holds a Bachelor’s in Specialist Practitioner/ Practice Nursing.

Gaynor Mates is currently employed as a Clinical Research Nurse for CK Aspire, working on a real world study. Before joining the company, she worked with the NHS for 30 years, the last 17 of which she spent as a Lead Respiratory Nurse Specialist. Gaynor holds an MSc and a BSc in Respiratory Disease Management and is an Independent Nurse Prescriber.

Louise Doyle
is Senior Research Safety Officer at CK Aspire. Having qualified as a Midwife in 2008, she has worked as a researcher in maternity, infection control, paediatric oncology and respiratory studies. Louise holds a Postgraduate Diploma in Clinical Research.

spacer
Julie Millar
spacer
spacer
spacer
Gaynor Mates
spacer
spacer
spacer
Louise Doyle
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Virtual Visit Capabilities Keep Clinical Trials on Track during COVID-19

ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a Virtual Visit solution that enables the continuation of clinical trials during and after current global stay-at-home mandates. As a result of COVID-19, many clinical trials have been delayed as healthcare providers focus their efforts on patients who require urgent care, which limits clinical trial patients’ access to investigative sites for routine visits.
More info >>

White Papers

New Temperature Profiles from a Global Study

Laminar Medica

Recently there has been an influx of temperature mapping studies to collect sufficient ambient data to develop temperature profiles.  Solid temperature profiles on specific shipping routes are required to ensure streamlined packaging and robust lane qualification. The most reliable method to develop temperature profiles is to capture the actual reading from shipments, as well as using the historical and meteorological data to increase the confidence level.
More info >>

 
Industry Events

Evolution Summit

20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement